Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Amortization of Deferred Charges (2018 - 2025)

Orthofix Medical's Amortization of Deferred Charges history spans 13 years, with the latest figure at $2.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges fell 82.52% year-over-year to $2.0 million, compared with a TTM value of $5.9 million through Dec 2025, down 62.68%, and an annual FY2025 reading of $5.9 million, down 62.68% over the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $2.0 million at Orthofix Medical, up from $1.6 million in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $11.3 million in Q4 2024, with the low at $735000.0 in Q4 2022.
  • Average Amortization of Deferred Charges over 5 years is $1.8 million, with a median of $1.2 million recorded in 2023.
  • Year-over-year, Amortization of Deferred Charges soared 307.07% in 2023 and then crashed 82.52% in 2025.
  • Tracing OFIX's Amortization of Deferred Charges over 5 years: stood at $851000.0 in 2021, then decreased by 13.63% to $735000.0 in 2022, then soared by 307.07% to $3.0 million in 2023, then surged by 277.67% to $11.3 million in 2024, then crashed by 82.52% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Amortization of Deferred Charges are $2.0 million (Q4 2025), $1.6 million (Q3 2025), and $1.1 million (Q2 2025).